1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ENTRADA THERAPEUTICS INC
Entrada Therapeutics Inc
XNAS: TRDA
11.53 -0.45 (-3.76%)
135.4K
XNAS Volume

XNAS 20 Mar, 2026 11:36 AM (EDT)

Watchlist

Portfolio

Alert

Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 7 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -2.0%, and profit growth estimate of -24.8% for FY26, based on top 7 analyst calls.